|
DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft
/ Key word(s): Half Year Results/Miscellaneous
Corporate News Bad Neustadt a. d. Saale | 5 August 2021 RHÖN-KLINIKUM AG closes first half of 2021 with increase in revenues In the first half of 2021, RHÖN-KLINIKUM AG's efforts to cope with the COVID-19 pandemic continued undiminished. Dr. Christian Höftberger, Chairman of the Board of Management of RHÖN-KLINIKUM AG, said: "Once again, the pandemic confronted us with extraordinary tasks. We have nonetheless done a good job at coping with the corona crisis. Looking forward, we are confident that we will continue our success in dealing with the related challenges, in particular the economic effects." From January to June 2021, a total of 414,489 patients were treated at our hospitals, 5.1% more than in the same period last year (previous year, 2020: 394,558). Revenues within the Group of RHÖN-KLINIKUM AG in the first half stood at € 682.8 million (previous year, 2020: € 670.5 million). At € 46.5 million, EBITDA exceeded the previous year's level of € 35.5 million. The EBITDA margin was 6.8%. Taking account of depreciation/amortisation, financing costs and taxes, EBITDA resulted in a consolidated profit of + € 8.6 million, after - € 3.7 million in the previous year. Synergies create sustainable corporate success The strategic partnership of RHÖN-KLINIKUM AG with Asklepios continues to move ahead apace. The feeling of common identity or "togetherness", networking, and the mutual transfer of know-how within the new corporate group continue to grow and are opening up new opportunities for all companies under the umbrella of the Asklepios Group. RHÖN-KLINIKUM AG is also seeking synergies with its service companies. As of immediately, the Company will amalgamate and pool in-house services and competences from the areas of technology and medical technology, sterile processing (RUMED) and catering at the Bad Neustadt a. d. Saale, Bad Berka and Frankfurt (Oder) hospital sites into the Group service companies RHÖN-KLINIKUM Services GmbH and RHÖN-Cateringgesellschaft mbH. Moreover, the IT and materials management/logistics areas are also to be centralised within the newly established subsidiaries RHÖN-KLINIKUM IT Service GmbH, RHÖN-KLINIKUM Service Einkauf + Versorgung GmbH and RHÖN-KLINIKUM Business Services GmbH. This will enable us to streamline structures and processes and to provide services as a one-stop shop, thus further improving quality and efficiency at all sites. Strengthening of telematics infrastructure (TI) State-of-the-art medical case is no longer conceivable without the use of information technology. And the digitalisation of the healthcare system is the statutory mandate required of all hospitals. It allows for new IT applications such as electronic patient files, eMedication plan, emergency management or tele-consultants, all of which are designed to improve patient care and make clinical processes more efficient. In this context, RHÖN-KLINIKUM AG is making substantial investments in digitalisation. This means completely reorganising network technology, server and data management as well as medical technology and nursing systems and creating new interfaces - a huge challenge for large and complex hospitals like RHÖN-KLINIKUM AG. Full results are published in the Quarterly Statement at:
Contact: RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury
05.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | RHÖN-KLINIKUM Aktiengesellschaft |
| Salzburger Leite 1 | |
| 97616 Bad Neustadt a.d.Saale | |
| Germany | |
| Phone: | +49 (0)9771 - 65-0 |
| Fax: | +49 (0)9771 - 97 467 |
| E-mail: | rka@rhoen-klinikum-ag.com |
| Internet: | www.rhoen-klinikum-ag.com |
| ISIN: | DE0007042301 |
| WKN: | 704230 |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1224214 |
| End of News | DGAP News Service |
|
|
1224214 05.08.2021
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
